Connect with us
GW Pharma Analyst Predicts Expidiolex CBD Drug Sales at $475 Million in 2020, Global Cannabis Sales at $15 Billion in 2019 GW Pharma Analyst Predicts Expidiolex CBD Drug Sales at $475 Million in 2020, Global Cannabis Sales at $15 Billion in 2019

Hemp Industry Updates

GW Pharma Analyst Predicts Epidiolex CBD Drug Sales at $475 Million in 2020, Global Cannabis Sales at $15 Billion in 2019

Epidiolex is a prescription cannabidiol drug that is used to treat seizures associated with specific syndromes such as Lennox-Gastaut syndrome...

More Posts